Last reviewed · How we verify
NCT03089463
Foot Assessment in People With Diabetes: A Quantitative Diagnostic Approach
trial testing Observation in Diabetes in 153 participants. Suspended.
30 November 2024
Quick facts
| Lead sponsor | Staffordshire University |
|---|---|
| Status | Suspended |
| Study type | OBSERVATIONAL |
| Enrollment | 153 |
| Start date | 27 November 2017 |
| Primary completion | 30 November 2024 |
| Estimated completion | 30 January 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Observation
Conditions studied
- Diabetes — all drugs for Diabetes →
- Diabetic Foot — all drugs for Diabetic Foot →
- Diabetes Complications — all drugs for Diabetes Complications →
- Diabetes; Neuropathic (Manifestation) — all drugs for Diabetes; Neuropathic (Manifestation) →
Sponsor
Staffordshire University
Who can join
18 and older, any sex, with Diabetes or Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational cohort study aims to develop a novel risk stratification system implementing biomechanics to aid in the prevention of diabetic foot ulcers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03089463
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observation
Trials testing the same drug.
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
- NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
- NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
- NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Staffordshire University trials
Trials by the same sponsor.
- NCT04630795 — ViscoTurf - Preventing Secondary Diabetic Foot Ulceration. · unknown
- NCT04469374 — Menopause Osteoporosis and Bone Intervention Using Lifestyle Exercise. · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03089463 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Staffordshire University
- Last refreshed: 18 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03089463.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing